呼吸器感染症に対するritipenem acoxilの使用経験

書誌事項

タイトル別名
  • Clinical studies of ritipenem acoxil

この論文をさがす

抄録

We evaluated the clinical efficacy and safety of ritipenem acoxil (RIPM-AC), a neworal penem antibiotic.<BR>RIPM-AC was administered to 10 patients with respiratory tract infections. Clinical response was good in 9 and fair in 1 patient.<BR>Adverse reactions were not observed. Abnormal laboratory values were noted in 2 patients (eosinophilia), but were not clinically significant.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ